10,677 results on '"SOFT tissue infections"'
Search Results
2. Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use (AIM-STOP)
- Author
-
Shivakumar Narayanan, Asst Professor
- Published
- 2024
3. The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- Author
-
National Institute of General Medical Sciences (NIGMS) and Matthew R. Rosengart, Professor
- Published
- 2024
4. Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial (FAAN-C)
- Author
-
Patient-Centered Outcomes Research Institute and Eric Coon, Associate Professor
- Published
- 2024
5. Community-acquired Staphylococcus aureus skin and soft tissue infection risk assessment using hotspot analysis and risk maps: the case of California emergency departments.
- Author
-
Morgan Bustamante, Brittany, Fejerman, Laura, May, Larissa, and Martínez-López, Beatriz
- Subjects
CA-MRSA ,CA-MSSA ,Geographic disparities ,Hotspot analysis ,Medical service study areas ,Place-based determinants ,Skin and soft tissue Infections ,Spatial analysis ,Staphylococcus aureus ,Adult ,Humans ,Staphylococcus aureus ,Soft Tissue Infections ,Methicillin-Resistant Staphylococcus aureus ,Bayes Theorem ,Staphylococcal Infections ,California ,Emergency Service ,Hospital - Abstract
BACKGROUND: Community-acquired Staphylococcus aureus (CA-Sa) skin and soft tissue infections (SSTIs) are historically associated with densely populated urban areas experiencing high poverty rates, intravenous drug use, and homelessness. However, the epidemiology of CA-Sa SSTIs in the United States has been poorly understood since the plateau of the Community-acquired Methicillin-resistant Staphylococcus aureus epidemic in 2010. This study examines the spatial variation of CA-Sa SSTIs in a large, geographically heterogeneous population and identifies neighborhood characteristics associated with increased infection risk. METHODS: Using a unique neighborhood boundary, California Medical Service Study Areas, a hotspot analysis, and estimates of neighborhood infection risk ratios were conducted for all CA-Sa SSTIs presented in non-Federal California emergency departments between 2016 and 2019. A Bayesian Poisson regression model evaluated the association between neighborhood-level infection risk and population structure, neighborhood poverty rates, and being a healthcare shortage area. RESULTS: Emergency departments in more rural and mountainous parts of California experienced a higher burden of CA-Sa SSTIs between 2016 and 2019. Neighborhoods with high infection rates were more likely to have a high percentage of adults living below the federal poverty level and be a designated healthcare shortage area. Measures of population structure were not associated with infection risk in California neighborhoods. CONCLUSIONS: Our results highlight a potential change in the epidemiology of CA-Sa SSTIs in California emergency departments. Future studies should investigate the CA-Sa burden in other geographies to identify whether this shift in epidemiology holds across other states and populations. Further, a more thorough evaluation of potential mechanisms for the clustering of infections seen across California neighborhoods is needed.
- Published
- 2024
6. Contemporary national outcomes of hyperbaric oxygen therapy in necrotizing soft tissue infections.
- Author
-
Toppen, William, Cho, Nam, Sareh, Sohail, Kjellberg, Anders, Medak, Anthony, Benharash, Peyman, and Lindholm, Peter
- Subjects
Humans ,Soft Tissue Infections ,Hyperbaric Oxygenation ,Retrospective Studies ,Hospitalization ,Costs and Cost Analysis ,Fasciitis ,Necrotizing - Abstract
BACKGROUND: The role of hyperbaric oxygen therapy (HBOT) in necrotizing soft tissue infections (NSTI) is mainly based on small retrospective studies. A previous study using the 1998-2009 National Inpatient Sample (NIS) found HBOT to be associated with decreased mortality in NSTI. Given the argument of advancements in critical care, we aimed to investigate the continued role of HBOT in NSTI. METHODS: The 2012-2020 National Inpatient Sample (NIS) was queried for NSTI admissions who received surgery. 60,481 patients between 2012-2020 were included, 600 (
- Published
- 2024
7. Treatment of Esthetic Complications with Peri-implant Soft Tissue: A Description of the "Apical Approach" Surgical Technique and Presentation of Two Clinical Cases.
- Author
-
Quispe-López, Norberto, Flores-Fraile, Javier, Fernández-Baca, Ignacio, Sánchez-Santos, Juan, Mena-Álvarez, Jesús, and Montero, Javier
- Subjects
OPERATIVE dentistry ,SOFT tissue infections ,COSMETIC dentistry ,CASE studies ,PERI-implantitis ,PERIODONTICS ,DISEASE complications - Abstract
Peri-implant soft tissue deformities are an increasingly common phenomenon in the esthetic zone. While the most widely studied esthetic complications are peri-implant soft tissue dehiscences, there are other esthetic concerns in routine clinical practice that require investigation and treatment. Thus, this report on two clinical cases describes a surgical approach using the apical access technique to treat peri-implant soft tissue discoloration and fenestration. In both clinical scenarios, the defect was accessed via a single horizontal apical incision without removing the cement-retained crowns. A bilaminar technique using apical access with a simultaneous connective tissue graft seems to offer promising results for the treatment of peri-implant soft tissue deformities. At the 12-month reevaluation, an increase in peri-implant soft tissue thickness was observed, resolving the pathologies presented. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
- Published
- 2024
9. HAT for the Treatment of Sepsis Associated With NASTI
- Author
-
The University of Kansas School of Medicine - Wichita
- Published
- 2024
10. Reinforced PTFE Meshes Versus Customized Titanium Meshes
- Author
-
Alessandro Cucchi, Principal Investigator
- Published
- 2024
11. Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
- Published
- 2024
12. PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)
- Published
- 2024
13. Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
- Author
-
Areg Grigorian, Assistant Clinical Professor, Surgery
- Published
- 2024
14. Potential medical impact of unrecognized in vitro hypokalemia due to hemolysis: a case series.
- Author
-
Wu, Alan H.B. and Peacock, W. Franklin
- Subjects
- *
SOFT tissue infections , *SHORT bowel syndrome , *BLOOD collection , *VENTRICULAR ejection fraction , *HEART failure - Abstract
The destruction of red cells during blood collection or with the processing of the sample continues to occur at a high rate, especially among emergency department (ED) patients. This can produce pre-analytical laboratory errors, particularly for potassium. We determined the incidence of hemolyzed samples and discuss the potential medical impact for hypokalemic patients who potassium level is artificially normal (pseudoeukalemia). Potassium results were obtained for a 6-month period. Using a measured hemolysis index (HI), hemolysis was present in 3.1 % for all potassium ordered (n=94,783) and 7.5 % for ED orders (n=22,770). Most of these samples were reported as having high normal result or were hyperkalemic. There were 22 hemolytic samples with a potassium of <3.5 mmol/L, and 57 hemolytic samples with a potassium in lower limit of normal (3.5–3.8 mmol/L). From this group, we examined the medical histories of 8 selected patients whose initially normal potassium levels were subsequently confirmed to have a potassium values that were below, at, or just above the lower limit of normal due to hemolysis. The primary complaint for these patients were: necrotizing soft tissue infection, pancreatitis, volume overload from heart failure with reduced ejection fraction, hypertension treated with hydrochlorothiazide, and presence of a short bowel syndrome. A subsequent non-hemolyzed sample was collected demonstrating hypokalemia in all of these patients. Within these cases, there was a potential for harm had hemolysis detection not been performed. We demonstrate the medical importance of detecting hemolysis for patients who have pseudoeukalemia. This is relevant because the HI cannot be obtained when electrolytes are tested using whole blood samples, and a normal potassium may lead to inappropriate patient management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Nekrotisierende Weichgewebsinfektionen.
- Author
-
Lanckohr, Christian, Horn, Dagmar, Roßlenbroich, Steffen, Raschke, Michael J., Hirsch, Tobias, and Stolberg-Stolberg, Josef
- Subjects
- *
ANTIBIOTICS , *SOFT tissue infections , *CRITICALLY ill , *PATIENTS , *NECROSIS , *FUNCTIONAL status , *NECROTIZING fasciitis , *SEPSIS , *INTENSIVE care units , *PLASTIC surgery , *PATIENT aftercare - Abstract
Necrotizing soft tissue infections are a heterogeneous group of severe infections of the skin, connective tissue and muscles in which necrotic destruction of the tissue occurs at the site of infection. Various bacteria are known as "typical" triggering pathogens and the infection can occur on the entire surface of the body. Necrotizing soft tissue infections are always a time-sensitive emergency associated with high mortality. Many affected patients are critically ill and require treatment in an intensive care unit. The rapid and radical surgical treatment is an essential part of management and in addition an adequate and timely antimicrobial treatment is of great importance. The health consequences for surviving patients are often severe, as extensive soft tissue damage leads to functional impairments. In many cases extensive plastic surgery follow-up is necessary. Therefore, necrotizing soft tissue infections are "complicated" in every phase of the disease and require interprofessional treatment. This review article provides a current overview of various aspects of the diagnostics, treatment and aftercare of necrotizing soft tissue infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Incidence and risk of infection in malignant soft tissue tumor resection: Data from the nationwide soft tissue tumor registry.
- Author
-
Morii, Takeshi, Sato, Kenji, Ogura, Koichi, and Kawai, Akira
- Subjects
- *
SOFT tissue tumors , *SOFT tissue infections , *PREOPERATIVE risk factors , *MUSCULOCUTANEOUS flaps , *LIMB salvage ,TUMOR surgery - Abstract
Postoperative infection is a devastating complication in limb salvage surgery for malignant soft tissue tumors. The low absolute case numbers of these rare cancers represent a bottleneck for data collection and analysis. The administration of nationwide registry data is a practical option for the accumulation of cases. Data on malignant soft tissue tumor resection were extracted from the Bone and Soft Tissue Tumor Registry in Japan. The incidence of postoperative infection and its risk factors were analyzed. A total of 14,460 cases were included. The incidence of infection was 2.6%. Significant risks for infection were male sex, lower extremity or trunk location, tumor diameter of over 10 cm, trans -compartmental invasion, high grade, autologous bone graft, myocutaneous flap, vascular reconstruction, reconstruction by prosthesis, postoperative radiotherapy, and delayed wound healing. The incidence was lower than those in the previous studies, perhaps because of less frequent radiotherapy application. Some of the significant risk factors represented local invasiveness of the tumor, suggesting the importance of the preservation of soft tissue for infection prevention. The administration of nationwide registry data was informative for the analysis of infection in malignant soft tissue tumor resection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Risk factors associated with severity, prognosis, and evolution of patients with tropical diabetic hand syndrome.
- Author
-
Ríos-Cantú, Arnulfo A., Garza-Cerna, Jorge A., Chacón-Moreno, Hernán, Castro-Govea, Yanko, Valdés-Flores, Everardo, and García-Pérez, Mauricio M.
- Subjects
- *
TROPICAL medicine , *AMPUTATION , *RISK assessment , *SOFT tissue infections , *HAND surgery , *BODY mass index , *GLYCOSYLATED hemoglobin , *QUALITATIVE research , *HAND abnormalities , *DISEASE management , *SCIENTIFIC observation , *FISHER exact test , *SEVERITY of illness index , *DISEASE remission , *QUANTITATIVE research , *CHI-squared test , *DESCRIPTIVE statistics , *DISEASES , *ODDS ratio , *TYPE 2 diabetes , *CONVALESCENCE , *SOCIODEMOGRAPHIC factors , *CONFIDENCE intervals , *DATA analysis software , *NUTRITION , *DISEASE risk factors , *DISEASE complications - Abstract
Objective: Tropical diabetic hand syndrome (TDHS) is rarely described and recognized in the literature as a complication in people with diabetes, and Mexico has high incidence rates of diabetes mellitus II (DMII). The minor or major amputation of the arm represents a physically and economically significant morbidity problem in patients. To optimize the diagnosis and treatment, in this work, we identify prognostic factors and their association with the severity of TDHS and the need for amputation in patients with diabetes mellitus and hand tissue infection. Methods: A total of 55 patients with a confirmed diagnosis of DMII with soft tissue infection in the hand referred to the plastic and reconstructive surgery department were studied for their evaluation and treatment. We analyze sociodemographic and clinical factors and follow-up of remission and recovery in limb functions. Results: In our study, we identified factors associated with amputation such as schooling under 6 years (OR: 21.98, confidence interval (CI): 1.21–3.98, p = 0.003), body mass index ≥ 20 (OR: 0.07, CI = 0.003–1.41, p = 0.031), and history of amputation (no upper limb) (OR: 5.9, CI = 1.11–32.1, p = 0.032). Furthermore, people with TDHS requiring amputation had slightly higher glycated hemoglobin (Hb1Ac) ≥ 10% (OR: 2.36, CI = 0.62–8.98, p = 0.338), and the risk of death was also increased (OR: 3.4, CI = 0.355–32.6, p = 0.288), although these outcomes did not reach statistical significance. Conclusions: Risk factors for amputation as a treatment of THDS are directly linked to lower schooling status, poor nutrition/low weight, as well as previous amputation procedures in patients. These data will help to establish a timelier evaluation and management in patients with suspected THDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Fasciite nécrosante postmastectomie et reconstruction mammaire immédiate par prothèse : premier cas rapporté.
- Author
-
Piette, E., Ungerer, L., Roulot, A., Walhin, N., Leymarie, N., and Romano, G.
- Subjects
- *
SOFT tissue infections , *NECROSIS , *SKIN physiology , *ANTIBIOTICS , *BREAST surgery - Abstract
La fasciite nécrosante est une infection rapidement progressive des tissus mous s'étendant de la peau au fascia et entraînant des nécroses étendues. Il s'agit d'une complication très rare mais grave avec une mortalité variant de 10 à 15 %. La prise en charge optimale relève d'un diagnostic précoce suivi d'un traitement associant antibiothérapie et parage chirurgical large dans les plus brefs délais. La localisation au niveau du sein est peu fréquente. Bien qu'il s'agisse le plus souvent de fasciites nécrosantes mammaires primaires, plusieurs cas de fasciites nécrosantes ont été rapportés dans les suites postopératoires d'une chirurgie mammaire. Nous présentons le cas d'une fasciite nécrosante du sein survenu après un geste de mastectomie par voie sous-mammaire avec reconstruction immédiate par implant prépectoral en silicone, ayant abouti à une défaillance multiviscérale suivi du décès de la patiente malgré une prise en charge médicochirurgicale intrahospitalière optimale. Il s'agit du premier cas survenu après une reconstruction mammaire immédiate. Necrotizing fasciitis is a rapidly progressive soft tissue infection extending from the skin to the fascia, resulting in extensive necrosis. It is a very rare but serious complication, with mortality ranging from 10 to 15%. Optimal management involves early diagnosis followed by treatment combining antibiotic therapy and wide surgical removal as soon as possible. Localisation in the breast is uncommon. Although most cases are primary necrotizing fasciitis of the breast, several cases of necrotizing fasciitis have been reported in the post-operative aftermath of breast surgery. We present a case of necrotizing fasciitis of the breast following submammary mastectomy with immediate reconstruction using a pre-pectoral silicone implant, which resulted in multiple organ failure and the death of the patient despite optimal medical and surgical management. This is the first case to occur after immediate breast reconstruction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Association between CDK4/6 inhibitors and drug‐related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System.
- Author
-
Go, Makiko, Noguchi, Yoshihiro, Masuda, Rikuto, Asano, Hiroki, Kimura, Michio, Usami, Eiseki, and Yoshimura, Tomoaki
- Subjects
CYCLIN-dependent kinase inhibitors ,OSTEONECROSIS ,SOFT tissue infections ,PHARMACOEPIDEMIOLOGY ,JAWS - Abstract
The most common toxicities associated with cyclin‐dependent kinase (CDK) 4/6 inhibitor therapy include decreased leukopenia and neutropenia due to the inhibition of CDK6 of leukocyte and neutrophil precursors in bone marrow. These hematological toxicities are more commonly observed with palbociclib administration than with abemaciclib administration, which is approximately 13 times more selective against CDK4 than CDK6. Thus, even though both successfully inhibit CDK4/6, the side effects of palbociclib and abemaciclib differ due to differences in selectivity. Recent reports have suggested an association between palbociclib and medication‐related osteonecrosis of the jaw; however, reports on this association are inconsistent. This study investigated the potential association of palbociclib and abemaciclib with MRONJ using the FAERS. Signals of "Osteonecrosis of jaw" were detected only in females using palbociclib (cROR025: 2.08). Other signals detected included stomatitis‐related adverse events with abemaciclib and intraoral soft tissue damage and infection with palbociclib. As previous exploratory studies have reported MRONJ signals for bisphosphonates and denosumab, we calculated the aROR for palbociclib‐induced osteonecrosis of the jaw using concomitant bisphosphonates and denosumab as covariates. A signal was detected even after adjusting for sex, age, and concomitant medications as covariates (aROR0025: 5.74). A proper understanding of the differences in CDK selectivity is necessary for the appropriate use of CDK4/6 inhibitors. To the best of our knowledge, this is the first report on CDK4/6 inhibitors and drug‐related osteonecrosis of the jaw. We believe that these results will offer new insights into adverse events related to the use of CDK4/6 inhibitors, and may aid in the proper use of CDK4/6 inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Tissue resident cells differentiate S. aureus from S. epidermidis via IL-1β following barrier disruption in healthy human skin.
- Author
-
Lang, Julia C., Brutscher, Andreas, Ehrström, Marcus, and Melican, Keira
- Subjects
- *
SOFT tissue infections , *STAPHYLOCOCCUS epidermidis , *HUMAN microbiota , *STAPHYLOCOCCUS aureus , *DRUG resistance in bacteria - Abstract
The Staphylococcus sp. are a dominant part of the human skin microbiome and present across the body. Staphylococcus epidermidis is a ubiquitous skin commensal, while S. aureus is thought to colonize at least 30% of the population. S. aureus are not only colonizers but a leading cause of skin and soft tissue infections and a critical healthcare concern. To understand how healthy human skin may differentiate commensal bacteria, such as S. epidermidis, from the potential pathogen methicillin-resistant S. aureus (MRSA), we use ex vivo human skin models that allow us to study this host-bacterial interaction in the most clinically relevant environment. Our work highlights the role of the outer stratum corneum as a protective physical barrier against invasion by colonizing Staphylococci. We show how the structural cells of the skin can internalize and respond to different Staphylococci with increasing sensitivity. In intact human skin, a discriminatory IL-1β response was identified, while disruption of the protective stratum corneum triggered an increased and more diverse immune response. We identified and localized tissue resident Langerhans cells (LCs) as a potential source of IL-1β and go on to show a dose-dependent response of MUTZ-LCs to S. aureus but not S. epidermidis. This suggests an important role of LCs in sensing and discriminating between bacteria in healthy human skin, particularly in intact skin and provides a detailed snapshot of how human skin differentiates between friend and potential foe. With the rise in antibiotic resistance, understanding the innate immune response of healthy skin may help us find ways to enhance or manipulate these natural defenses to prevent invasive infection. Author summary: How healthy human skin can differentiate between commensal bacteria that live harmoniously on our skin and those bacteria that have the potential to cause invasive infection, is of great interest. Here we use ex vivo human skin models to show how the outer layer of human skin resists bacterial invasion and that disruption of this layer leads to increased infection and inflammation. We show how colonization of both intact and disrupted skin by Staphylococcus aureus causes an increased IL-1β signaling compared to the commensal S. epidermidis. We show that tissue resident Langerhans cells are well positioned throughout the skin epidermis and that MUTZ-LCs can differentiate commensal from pathogen via IL-1β. This work identifies one of the subtle, yet effective, pathways by which human skin differentiates commensals and pathogens. Understanding these mechanisms could lead to potential new treatment and prevention targets, mechanisms by which we can enhance innate immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Comparative analysis of healthcare resource utilization: necrotizing soft tissue infections versus burn injuries.
- Author
-
Shukla, Nupur, Angliss, Marg, Paul, Eldho, and Bruscino-Raiola, Frank
- Subjects
- *
APACHE (Disease classification system) , *SOFT tissue infections , *BODY surface area , *REHABILITATION centers , *LENGTH of stay in hospitals - Abstract
Background: Necrotising soft tissue infections (NSTI) and burn injuries pose substantial challenges in clinical management, necessitating multidisciplinary approaches. This study compares outcomes between NSTI and burn patients, emphasising the resource disparity. Methods: 93 NSTI patients admitted between January 2014 and December 2021 were matched with burns patients by total body surface area (TBSA), gender, and age. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a score utilised to predict mortality. Length of stay in hospital, length of intensive care unit (ICU) admission and disposition were also collected. Results: Our study shows higher APACHE II scores in NSTI patients (median 24 vs. 6 in burns), leading to elevated post-operative mortality (30% vs. 3% in burns) and non-operative mortality (40% vs. 8% in burns). NSTI patients had longer hospital stays and more required transfers to other facilities such as rehabilitation centres compared to burns. Conclusions: These findings highlight the substantial resource demands of managing NSTI patients, underscoring the urgent need for additional funding and optimised resource allocation to improve outcomes in this population. Level of Evidence: Level III, risk/prognostic study [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study.
- Author
-
Tsai, Serena Yun‐Chen, Gaffin, Jonathan M., Hawryluk, Elena B., Ruran, Hana B., Bartnikas, Lisa M., Oyoshi, Michiko K., Schneider, Lynda C., Phipatanakul, Wanda, and Ma, Kevin Sheng‐Kai
- Subjects
- *
MENTAL illness , *SOFT tissue infections , *ATTENTION-deficit hyperactivity disorder , *ATOPIC dermatitis , *SLEEP interruptions - Abstract
Background Methods Results Conclusions Dupilumab is the first and only biologic agent approved for the treatment of atopic dermatitis (AD) in pediatric patients aged from 6 months to 17 years. The study aimed to evaluate the impact of dupilumab on the occurrence of comorbidities in pediatric patients with AD.In this population‐based cohort study, we utilized electronic health records from multiple healthcare organizations across the United States. Pediatric patients (<18 years of age) with a diagnosis of AD initiating dupilumab were propensity‐score matched 1:1 to those initiating other systemic agents (azathioprine, cyclosporine, methotrexate, mycophenolate mofetil, or systemic corticosteroids). The primary outcomes were new‐onset comorbidities emerging during the study period measured by the risk ratio (RR) and its confidence interval (CI). Subgroup analyses were stratified by age (0–5 years, 6–11 years, and 12–17 years), sex, and race.A total of 3575 pediatric patients with AD treated with dupilumab were matched to 3575 patients treated with other systemic agents. The dupilumab cohort was associated with a lowered risk of new‐onset atopic comorbidities (including asthma [RR, 0.72; 95% CI, 0.59–0.89] and allergic rhinitis [RR, 0.62; 95% CI, 0.52–0.74]), infections (e.g., skin and soft tissue infection [RR, 0.70; 95% CI, 0.63–0.76] and respiratory tract infection [RR = 0.56; 95% CI, 0.51–0.61]), psychiatric disorders (e.g., mood disorder [RR, 0.52; 95% CI, 0.39–0.70] and anxiety [RR, 0.57; 95% CI, 0.46–0.70], sleep disturbance [RR, 0.60; 95% CI, 0.47–0.77]), neurologic and developmental disorders (e.g., attention deficit hyperactivity disorder [RR, 0.54; 95% CI, 0.38–0.75]). Furthermore, the positive effects are found to be more pronounced in younger children (aged 0–5 years) with AD.Treatment with dupilumab compared to systemic agents resulted in reductions in AD‐related comorbidities in pediatric patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Effective Management of Methicillin-Resistant Shoulder Septic Arthritis Using Continuous Local Antibiotic Perfusion: A Case Study and Long-Term Follow-Up.
- Author
-
Shunya Yamaguchi, Shusuke Ueda, Toru Ichiseki, Daisuke Soma, Ayumi Kaneuji, and Norio Kawahara
- Subjects
- *
INFECTIOUS arthritis , *SOFT tissue infections , *SHOULDER joint , *DRUG monitoring , *SHOULDER , *PERFUSION - Abstract
Objective: Rare disease Background: Septic arthritis of the shoulder is a rare and challenging condition to treat. Typically, arthroscopic debridement is the common approach. Specifically, septic arthritis of the shoulder caused by methicillin-resistant bacteria is extremely difficult to cure due to persistent infection and limited antibiotic options. However, recent studies have demonstrated that continuous local antibiotic perfusion (CLAP) can provide favorable results for bone and soft tissue infections. By administering the antibiotics required to suppress the biofilm, CLAP can effectively treat the infection while sparing the tissue. Case Report: A 46-year-old woman undergoing long-term hemodialysis treatment for congenital anomalies of the kidney and urinary tract experienced severe pain in the left shoulder joint during glucocorticoid treatment for amyloid arthritis of the right shoulder. Despite the absence of fever, significant swelling and fluid accumulation were observed in the left shoulder joint, leading to the performance of a puncture. A bacterial examination of the puncture fluid detected methicillin-resistant coagulase-negative Staphylococcus epidermidis (MRCNS). In this report, we present a case in which CLAP was administered for septic arthritis of the shoulder caused by methicillin-resistant bacteria. After irrigation debridement, the patient received intravenous antibiotics and CLAP. Following the initiation of treatment, the dosage of antibiotics was adjusted while performing therapeutic drug monitoring. An early improvement in the inflammatory response and sedation of the infection was observed, with no relapse after 2 years. Conclusions: Septic arthritis can lead to serious functional impairment if left untreated. CLAP is a promising option for managing septic arthritis of the shoulder. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Isolated remote site musculoskeletal Mycobacterium bovis infections after BCG immunisation in immunocompetent children.
- Author
-
Jiawen Fong, Sinn Yii Chia, Dawn, Ming Chew, Darryl Ee, and Leung Wong, Kenneth Pak
- Subjects
- *
SOFT tissue infections , *IRON deficiency anemia , *ANATOMICAL planes , *BCG vaccines , *MYCOBACTERIAL diseases , *TUBERCULIN test , *LYMPHADENITIS , *KNEE pain - Abstract
This article discusses the occurrence of musculoskeletal infections in immunocompetent children after receiving the BCG immunization. The study examines the clinical characteristics of these infections, focusing on extremity bone and soft tissue infections. The article emphasizes the rarity of these infections in immunocompetent children and the need for more evidence-based research on the topic. Treatment typically involves a combination of antibiotics and may require surgical intervention. Early diagnosis and treatment are crucial to prevent complications, and further research is needed to improve outcomes for these infections in children. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
25. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings.
- Author
-
LoVecchio, Frank, McCarthy, Matthew W., Ye, Xiaolan, Henry, Alasdair D., Doan, Quan V., Lock, John L., Riccobene, Todd, Lyles, Rosie D., and Talan, David A.
- Subjects
- *
LENGTH of stay in hospitals , *SOFT tissue infections , *EMERGENCY room visits , *INPATIENT care , *PROPRIETARY hospitals , *EMERGENCY physicians - Abstract
• Skin/soft tissue infections significantly contribute to hospitalizations in the United States. • Hospitalizations are often required to administer multidose IV antibiotics. • A single IV dose dalbavancin pathway was previously implemented at 11 US EDs. • Costs associated with the pathway were compared with those of inpatient usual care. • $5133.20 per-patient savings were observed for US for-profit hospitals. A pathway for the treatment of acute bacterial skin and skin structure infections (ABSSSI) with a single intravenous (IV) dose of dalbavancin was previously shown to reduce hospital admissions and shorten inpatient length of stay (LOS). To describe pathway implementation at the emergency department (ED) and evaluate cost-effectiveness of a single-dose dalbavancin administered to ED patients who would otherwise be hospitalized to receive usual care with multidose IV antibiotics. The dalbavancin pathway was previously implemented at 11 U.S. EDs (doi:10.1111/acem.14258). Patients with ABSSSI, without an unstable comorbidity or infection complication requiring complex management, were treated with a single dose of dalbavancin. At the emergency physicians' discretion, patients were either discharged and received outpatient follow-up or were hospitalized for continued management. A decision analytic cost-effectiveness model was developed from the U.S. healthcare's perspective to evaluate costs associated with the dalbavancin pathway compared with inpatient usual care. Costs (2021 USD) were modeled over a 14-day horizon and included ED visits, drug costs, inpatient stay, and physician visits. One-way and probabilistic sensitivity analyses examined input parameter uncertainty. Driven largely by the per diem inpatient cost and LOS for usual care, the dalbavancin pathway was associated with savings of $5133.20 per patient and $1211.57 per hospitalization day avoided, compared with inpatient usual care. The results remained robust in sensitivity and scenario analyses. The new single-dose dalbavancin ED pathway for ABSSSI treatment, which was previously implemented at 11 U.S. EDs, offers robust cost savings compared to inpatient usual care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Association between Insurance Status and Outcomes of Hospitalizations for Necrotizing Soft Tissue Infections.
- Author
-
Uwumiro, Fidelis, Okpujie, Victory, Ajiboye, Adetayo, Abesin, Olawale, Ogunfuwa, Olamide, Mojeed, Opeyemi, Borowa, Azabi, Alemenzohu, Hillary, Hassan, Judith, and Ajayi, Oluwadamilola
- Subjects
- *
GAS gangrene , *SOFT tissue infections , *HEALTH maintenance organizations , *FOURNIER gangrene , *NECROTIZING fasciitis - Abstract
Background: Lack of insurance is associated with poorer outcomes in hospitalized patients. However, few studies have explored this association in hospitalizations for necrotizing soft tissue infections (NSTIs). This study examined the impact of insurance status on the outcome of NSTI admissions. Methods: All adult hospitalizations for necrotizing fasciitis, gas gangrene, and Fournier gangrene between 2016 and 2018 were examined using the Nationwide Inpatient Sample database. Insurance status was categorized as insured (including Medicare, Medicaid, and Private, including Health maintenance organization (HMO) or uninsured (Self-pay). Outcome measures included mortality rates, limb loss, length of hospital stay, prolonged hospital stay, and critical care admissions. Statistical analysis included weighted sample analysis, chi-square tests, multivariate regression analysis, and negative binomial regression modeling. Results: Approximately 29,705 adult hospitalizations for NSTIs were analyzed. Of these, 57.4% (17,065) were due to necrotizing fasciitis, 22% (6,545) to gas gangrene, and 20.5% (6,095) to Fournier gangrene. Approximately 9.7% (2,875) were uninsured, whereas 70% (26,780) had insurance coverage. Among the insured, Medicare covered 39.6% (10,605), Medicaid 29% (7,775), and private insurance 31.4% (8,400). After adjustments, Medicare insurance was associated with greater odds of mortality (adjusted odds ratio [aOR]: 1.81; 95% confidence interval [CI]: 1.33–2.47; p = 0.001). Medicaid insurance was associated with increased odds of amputation (aOR: 1.81; 95% CI: 1.33–2.47; p < 0.001), whereas private insurance was associated with lower odds of amputation (aOR: 0.70; 95% CI: 0.51–0.97; p = 0.030). Medicaid insurance was associated with greater odds of prolonged hospital stay (aOR: 1.34; 95% CI: 1.09–1.64; p < 0.001). No significant association was observed between the lack of insurance or self-pay and the odds of primary or secondary outcomes. Conclusion: Medicare insurance was correlated with greater odds of mortality, whereas Medicaid insurance was associated with increased odds of amputation and longer hospital stay. Uninsured status was not associated with significant differences in NSTI outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Cellulitis in the Emergency Department: A prospective cohort study with patient‐centred follow‐up.
- Author
-
Nightingale, Rachael S, Etheridge, Nimai, Sweeny, Amy L, Smyth, Graham, Dace, William, Pellatt, Richard A.F., Snelling, Peter J, Yadav, Krishan, and Keijzers, Gerben
- Subjects
- *
ANTIBIOTICS , *CELLULITIS treatment , *CELLULITIS , *SOFT tissue infections , *ERYTHEMA , *RESEARCH funding , *EDEMA , *SCIENTIFIC observation , *QUESTIONNAIRES , *HOSPITAL emergency services , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *LONGITUDINAL method , *ORBITAL diseases , *PAIN , *ELECTRONIC health records , *HEALTH outcome assessment , *TREATMENT failure , *COMPARATIVE studies - Abstract
Objective: There is substantial practice variation in the management of cellulitis with limited prospective studies describing the course of cellulitis after diagnosis. We aimed to describe the demographics, clinical features (erythema, warmth, swelling and pain), patient‐reported disease trajectory and medium‐term follow‐up for ED patients with cellulitis. Methods: Prospective observational cohort study of adults diagnosed with cellulitis in two EDs in Southeast Queensland, Australia. Patients with (peri)orbital cellulitis and abscess were excluded. Data were obtained from a baseline questionnaire, electronic medical records and follow‐up questionnaires at 3, 7 and 14 days. Clinician adjudication of day 14 cellulitis cure was compared to patient assessment. Descriptive analyses were conducted. Results: Three‐hundred patients (mean age 50 years, SD 19.9) with cellulitis were enrolled, predominantly affecting the lower limb (75%). Cellulitis features showed greatest improvement between enrolment and day 3. Clinical improvement continued gradually at days 7 and 14 with persistent skin erythema (41%) and swelling (37%) at day 14. Skin warmth was the feature most likely to be resolved at each time point. There was a discrepancy in clinician and patient assessment of cellulitis cure at day 14 (85.8% vs. 52.8% cured). Conclusions: A clinical response of cellulitis features can be expected at day 3 with ongoing slower improvement over time. Over one third of patients had erythema or swelling at day 14. Patients are less likely than clinicians to deem their cellulitis cured at day 14. Future research should include parallel patient and clinician evaluation of cellulitis to help develop clearer definitions of treatment failure and cure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Group A Streptococcal meningitis in children: a short case series and systematic review.
- Author
-
Dou, Zhen-zhen, Li, Wanrong, Hu, Hui-Li, Guo, Xin, Hu, Bing, Chen, Tian-ming, Chen, He-ying, Guo, Ling-yun, and Liu, Gang
- Subjects
- *
SOFT tissue infections , *MENINGITIS , *CEREBROSPINAL fluid leak , *DEATH rate - Abstract
Background: Group A streptococcal(GAS) meningitis is a severe disease with a high case fatality rate. In the era of increasing GAS meningitis, our understanding about this disease is limited. Purpose: To gain a better understanding about GAS meningitis. Methods: Five new cases with GAS meningitis were reported. GAS meningitis related literatures were searched for systematic review in PUBMED and EMBASE. Case reports and case series on paediatric cases were included. Information on demographics, risk factors, symptoms, treatments, outcomes, and emm types of GAS was summarized. Results: Totally 263 cases were included. Among 100 individuals, 9.9% (8/81) had prior varicella, 11.1% (9/81) had anatomical factors, and 53.2% (42/79) had extracranial infections. Soft tissue infections were common among infants (10/29, 34.5%), while ear/sinus infections were more prevalent in children ≥ 3 years (21/42, 50.0%). The overall case fatality rate (CFR) was 16.2% (12/74). High risk of death was found in patients with shock or systemic complications, young children(< 3 years) and cases related to hematogenic spread. The predominate cause of death was shock(6/8). Among the 163 patients included in case series studies, ear/sinus infections ranged from 21.4 to 62.5%, while STSS/shock ranged from 12.5 to 35.7%, and the CFR ranged from 5.9 to 42.9%. Conclusions: A history of varicella, soft tissue infections, parameningeal infections and CSF leaks are important clinical clues to GAS in children with meningitis. Young children and hematogenic spread related cases need to be closely monitored for shock due to the high risk of death. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.
- Author
-
DEL ROSSO, JAMES Q., ARMILLEI, MARIA K., LOMAKIN, IVAN B., GRADA, AYMAN, and BUNICK, CHRISTOPHER G.
- Subjects
- *
SOFT tissue infections , *ACNE , *ANTIMICROBIAL stewardship , *ANAEROBIC bacteria , *STRUCTURE-activity relationships - Abstract
Clindamycin is a lincosamide antibiotic that has been used as a topical, oral, or injectable formulation for over five decades. It exhibits a narrow spectrum of microbiologic activity, primarily against gram-positive and anaerobic bacteria. In dermatology, clindamycin has been used primarily as a topical agent, usually for the treatment of acne vulgaris. Despite questions surrounding antibiotic resistance and/or its relative contribution to antibiotic treatment efficacy, a large body of data support the therapeutic value of topical clindamycin for acne vulgaris. As a systemic agent, clindamycin is used orally to treat a variety of cutaneous bacterial infections, and sometimes for acne vulgaris, with oral treatment for the latter less common in more recent years. The modes of action of clindamycin are supported by data showing both its anti-inflammatory and antibiotic mechanisms, which are discussed here along with pharmacokinetic profiles and structure-activity relationships. The diverse applications of clindamycin for multiple disease states, its efficacy, and safety considerations are also reviewed here, including for both topical and systemic formulations. Emphasis is placed on uses in dermatology, but other information on clindamycin relevant to clinicians is also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
30. Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study.
- Author
-
Ong, Sean W X, Luo, Jin, Fridman, Daniel J, Lee, Samantha M, Johnstone, Jennie, Schwartz, Kevin L, Diong, Christina, Patel, Samir N, Macfadden, Derek R, Langford, Bradley J, Tong, Steven Y C, Brown, Kevin A, and Daneman, Nick
- Subjects
- *
SOFT tissue infections , *BACTEREMIA , *LOGISTIC regression analysis , *DRUG resistance in microorganisms , *GRAM-negative bacteria , *NOSOCOMIAL infections - Abstract
Objectives The risk factors and outcomes associated with persistent bacteraemia in Gram-negative bloodstream infection (GN-BSI) are not well described. We conducted a follow-on analysis of a retrospective population-wide cohort to characterize persistent bacteraemia in patients with GN-BSI. Methods We included all hospitalized patients >18 years old with GN-BSI between April 2017 and December 2021 in Ontario who received follow-up blood culture (FUBC) 2–5 days after the index positive blood culture. Persistent bacteraemia was defined as having a positive FUBC with the same Gram-negative organism as the index blood culture. We identified variables independently associated with persistent bacteraemia in a multivariable logistic regression model. We evaluated whether persistent bacteraemia was associated with increased odds of 30- and 90-day all-cause mortality using multivariable logistic regression models adjusted for potential confounders. Results In this study, 8807 patients were included; 600 (6.8%) had persistent bacteraemia. Having a permanent catheter, antimicrobial resistance, nosocomial infection, ICU admission, respiratory or skin and soft tissue source of infection, and infection by a non-fermenter or non-Enterobacterales/anaerobic organism were associated with increased odds of having persistent bacteraemia. The 30-day mortality was 17.2% versus 9.6% in those with and without persistent bacteraemia (aOR 1.65, 95% CI 1.29–2.11), while 90-day mortality was 25.5% versus 16.9%, respectively (aOR 1.53, 95% CI 1.24–1.89). Prevalence and odds of developing persistent bacteraemia varied widely depending on causative organism. Conclusions Persistent bacteraemia is uncommon in GN-BSI but is associated with poorer outcomes. A validated risk stratification tool may be useful to identify patients with persistent bacteraemia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Clinical features of pasteurellosis without an animal bite or scratch in comparison with bite/scratch pasteurellosis.
- Author
-
Asaeda, Tsubasa, Ueda, Takashi, Nozaki, Yasuhiro, Murakami, Yasushi, Morosawa, Mika, Inaba, Hiroko, Ogashiwa, Hitoshi, Doi, Miki, Nakajima, Kazuhiko, Shirakawa, Manabu, Nakamura, Akifumi, Ikeda, Naoto, Sugiyama, Yuya, Wada, Yoshihiro, Ito, Takahiro, and Takesue, Yoshio
- Subjects
- *
BITES & stings , *SOFT tissue infections , *TIME-of-flight mass spectrometry , *PASTEURELLA multocida , *VENTILATOR-associated pneumonia , *INTRACRANIAL pressure - Abstract
Pasteurellosis is a common zoonotic infection that occurs after an animal bite or scratch (B/S). We compared the clinical features of six patients with non-B/S pasteurellosis with those of 14 patients with B/S infections. Pasteurella multocida was identified with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in all six non-B/S infections, whereas 13 of the 14 B/S infections were identified with diagnostic kits. The non-B/S infections were pneumonia (n = 3), skin and soft tissue infections (n = 2), and bacteremia (n = 1). Pneumonia occurred in two patients with underlying pulmonary disease, whereas ventilator-associated pneumonia developed in one patient with cerebral infarction. Pasteurella multocida was isolated from a blood specimen and nasal swab from a patient with liver cirrhosis (Child−Pugh class C) and diabetes. Cellulitis developed in one patient with diabetes and normal-pressure hydrocephalus, who had an open wound following a fall, and in one patient with diabetes and a foot ulcer. Three patients with non-B/S infections had no pet and no episode of recent animal contact. The rate of moderate-to-severe comorbidities was significantly higher in patients with non-B/S infections than in those with B/S infections (100% and 14.3%, respectively, p < 0.001). In conclusion, non-B/S infections can develop in patients with chronic pulmonary disease, invasive mechanical ventilation, or open wounds, or who are immunocompromised, irrespective of obvious animal exposure. In contrast to B/S infections, non-B/S pasteurellosis should be considered opportunistic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Successful management of surgical site infection caused by Mycobacterium mageritense in a breast cancer patient.
- Author
-
Akazawa, Nana, Itoh, Naoya, Ishibana, Yuichi, Murakami, Hiromi, and Okumura, Seiko
- Subjects
- *
SURGICAL site infections , *SOFT tissue infections , *MYCOBACTERIAL diseases , *BREAST cancer , *TIME-of-flight mass spectrometry , *BREAST cancer surgery - Abstract
Mycobacterium mageritense (M. mageritense), a nontuberculous mycobacterium, is classified as a rapidly growing mycobacterium, class IV in the Runyon Classification. This bacterium is found in soil, water, and other habitats. Infections caused by M. mageritense are relatively rare and no treatment protocol has been established. Herein, we report a case of skin and soft tissue infection caused by M. mageritense. A 49-year-old woman underwent surgery for right breast cancer. Four months after surgery, a surgical site infection was found, and M. mageritense was identified in the wound culture using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Based on the sensitivity results, the patient was treated with levofloxacin and doxycycline for 4 months. In addition to antimicrobial agents, aggressive surgical interventions led to a favorable course of treatment. In conclusion, successful treatment of skin and soft tissue infections with M. mageritense requires surgical intervention whenever possible, aggressive susceptibility testing, and appropriate antimicrobial therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Review of the Adverse Effects Associated with Dermal Filler Treatments: Part I Nodules, Granuloma, and Migration.
- Author
-
Hong, Gi-Woong, Hu, Hyewon, Chang, Kathleen, Park, Youngjin, Lee, Kar Wai Alvin, Chan, Lisa Kwin Wah, and Yi, Kyu-Ho
- Subjects
- *
FOREIGN body reaction , *SOFT tissue infections , *MINIMALLY invasive procedures , *ALLERGIES , *PATIENT safety - Abstract
The increase in the use of filler treatments within minimally invasive cosmetic surgery has correspondingly escalated the variety and frequency of associated side effects. Initially, unregulated procedures led to primary side effects such as infections, foreign body reactions, and granuloma formation. However, severe vascular complications like skin and tissue necrosis and blindness have emerged as recognized risks. Side effects from filler treatments can range from mild to life-threatening, including edema, pain, tenderness, numbness, bleeding, bruising, hematoma, redness, erythema, pigmentation, allergic reactions, itching, pruritus, the Tyndall effect, asymmetry, irregularity, migration, skin and soft tissue infections, nodules, granulomas, and vascular compromise. These side effects are categorized into early and delayed types. Many complications, particularly those related to vascular abnormalities, are frequently linked to procedural issues, emphasizing the importance of understanding filler properties, injection techniques, and facial anatomy. Preventing side effects is ideal, but early detection and treatment are crucial. Recognizing potential side effects based on their timing and understanding appropriate preemptive treatment methods is essential. This discussion addresses non-vascular side effects, highlighting their onset, symptoms, and management strategies. The comprehensive understanding and careful management of these side effects are vital for minimizing complications and ensuring patient safety in filler treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treat Streptococcus pyogenes skin and soft tissue infection.
- Author
-
Zongsen Zou, Singh, Pardeep, Pinkner, Jerome S., Obernuefemann, Chloe L. P., Wei Xu, Nye, Taylor M., Dodson, Karen W., Almqvist, Fredrik, Hultgren, Scott J., and Caparon, Michael G.
- Subjects
- *
SOFT tissue infections , *STREPTOCOCCUS pyogenes , *CHEMICAL libraries , *WOUND healing - Abstract
We have developed GmPcides from a peptidomimetic dihydrothiazolo ring-fused 2-pyridone scaffold that has antimicrobial activities against a broad spectrum of Gram-positive pathogens. Here, we examine the treatment efficacy of GmPcides using skin and soft tissue infection (SSTI) and biofilm formation models by Streptococcus pyogenes. Screening our compound library for minimal inhibitory (MIC) and minimal bactericidal (MBC) concentrations identified GmPcide PS757 as highly active against S. pyogenes. Treatment of S. pyogenes biofilm with PS757 revealed robust efficacy against all phases of biofilm formation by preventing initial biofilm development, ceasing biofilm maturation and eradicating mature biofilm. In a murine model of S. pyogenes SSTI, subcutaneous delivery of PS757 resulted in reduced levels of tissue damage, decreased bacterial burdens, and accelerated rates of wound healing, which were associated with down-regulation of key virulence factors, including M protein and the SpeB cysteine protease. These data demonstrate that GmPcides show considerable promise for treating S. pyogenes infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database.
- Author
-
Imai, Takanori, Kato, Naoto, Kanda, Naoki, Hashimoto, Hideki, Yamana, Hayato, and Hatakeyama, Shuji
- Subjects
- *
BACTERIAL diseases , *SOFT tissue infections , *FOURNIER gangrene , *URINARY tract infections , *DATABASES - Abstract
Introduction: The association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and the risk of urogenital infections remains controversial. This study aimed to investigate the association between SGLT2 inhibitors and the incidence of perineal soft tissue infections, including Fournier's gangrene (FG), genital bacterial infections, and urinary tract infections (UTIs), using administrative claims data in Japan. Methods: In this retrospective cohort study, we utilized the JMDC Claims Database. The study included patients aged 18 years or older diagnosed with type 2 diabetes mellitus, identified by a diagnostic code, who received new prescriptions for SGLT2 inhibitors or dipeptidyl peptidase 4 (DPP-4) inhibitors between April 2014 and August 2020. Using one-to-one propensity score (PS) matching, we compared the incidence of perineal soft tissue infections, including FG, genital bacterial infection, and UTIs between groups treated with SGLT2 and DPP-4 inhibitors. Hazard ratios (HR) and their 95% confidence intervals (CI) were estimated using the Cox proportional hazards model. Results: We identified 34,897 patients in the SGLT2 inhibitor group and 135,311 patients in the DPP-4 inhibitor group. After one-to-one PS matching, 31,665 pairs were generated. The mean age of the patients was 51 years, with approximately 70% being male. The use of SGLT2 inhibitors was associated with a decreased risk of UTI (HR 0.90, 95% CI 0.83–0.98) and an increased risk of genital bacterial infection (HR 1.23, 95% CI 1.03–1.46) compared to DPP-4 inhibitors. However, no significant association was observed with perineal soft tissue infection (HR 1.05, 95% CI 0.61–1.81). Conclusions: SGLT2 inhibitors were associated with a reduced risk of UTI and an increased risk of genital bacterial infection. They showed no significant association with perineal soft tissue infection when compared to DPP-4 inhibitors. Future research should explore broader demographics, focusing on the elderly and achieving gender balance, to gain a comprehensive understanding of infection risks. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. What Is a Surgical Site Infection After Carpal Tunnel Release?
- Author
-
Sandefur, Evan P., Beck, Jadon H., Vest, Maxwell O., Yu-Shan, Andrea A., Vaughn, Natalie H., and Apel, Peter J.
- Abstract
Considerable variation exists in the literature on published rates of surgical site infection (SSI) after carpal tunnel release, ranging over 20-fold, from 0.28% to 6.4%. The reason for this variability is unknown. A retrospective review was conducted on 748 open carpal tunnel releases performed under wide-awake local anesthetic no tourniquet in an in-office procedure room. The following three different definitions of infection were used for analysis: definition A: prescription of an oral antibiotic; Definition B: SSI definition by the Centers for Disease Control and Prevention; Definition C: infection that required reoperation. Infection rate by definition A was 8.9% (67/748), by definition B was 2.3% (17/748), and by definition C was 0.4% (3/748), resulting in a 22-fold range. The infection rate after carpal tunnel release is heavily influenced by the definition of SSI. The definition of SSI needs to be considered when making comparisons, either in research or quality assurance/quality improvement applications. When analyzing SSI rates, the exact definition of infection must be ascertained to accurately compare an individual's practice or institutional data to the literature. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Use of oxazolidinones (linezolid or tedizolid) for the treatment of breast infections. A case series from a tertiary referral hospital.
- Author
-
Kirkegaard, Cristina, Parramón-Teixidó, Carlos Javier, Morales-Comas, Clara, Clemente Bautista, Susana, Rivero Deniz, Joaquín, and Fernández-Hidalgo, Nuria
- Subjects
SOFT tissue infections ,CYTOPENIA ,BETA lactam antibiotics ,SALVAGE therapy ,SEROTONIN uptake inhibitors ,SYMPTOMS ,TREATMENT effectiveness ,TERTIARY care ,RETROSPECTIVE studies ,METHICILLIN-resistant staphylococcus aureus ,DESCRIPTIVE statistics ,SKIN ,CLINDAMYCIN ,ALTERNATIVE medicine ,LINEZOLID ,MASTITIS ,CASE studies ,BREAST ,GRAM-positive bacteria ,IMMUNOSUPPRESSION - Abstract
Objectives: Mastitis is mainly caused by Gram-positive bacteria and usually involves treatment with beta-lactam antibiotics and clindamycin. Oxazolidinones show good results in the treatment of skin and soft tissue infections (SSTIs) due to its pharmacokinetic characteristics. We aimed to describe clinical characteristics and outcomes of patients who received oxazolidinones for the treatment of SSTIs of the mammary tissue. Methods: Retrospective single-centre study of patients with a diagnosis of breast infection who received treatment with oxazolidinones as initial or salvage therapy between September 2016 and November 2022. Patients were identified through the pharmacy database. The primary outcome was clinical cure. Results: Twenty-nine patients received oxazolidinones: 27 received linezolid and 2 tedizolid. Median age was 41 years (IQR 31.0–56.5) and 28 patients were female. Ten patients (35%) had a history of breast cancer, while three (10%) had an immunosuppressive condition. Microbiological isolation was obtained in 24 individuals (83%). Predominant isolations were methicillin-resistant Staphylococcus aureus (8, 28%) and methicillin-susceptible S. aureus (7, 24%). Twenty-four patients (83%) received oxazolidinones as a salvage therapy, with a median duration of 14 days (IQR 10–17). Clinical cure was achieved in 24 patients (83%), while 4 relapsed after a median of 15 days (IQR 4–34). One was lost to follow-up. Three patients (10%) were taking selective serotonin reuptake inhibitors, and one of them concurrently received linezolid for 4 days with no adverse events recorded. Cytopenia during treatment was observed in 2/12 individuals. Oxazolidinones allowed hospital discharge in 11/13 hospitalized patients. Conclusions: Oxazolidinones could be considered as an alternative for treating breast infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Exploring therapeutic options for mild diabetic-related foot infections: a comparative in vitro study of cefditoren versus amoxicillin/clavulanic acid.
- Author
-
Alou, Luis, Gómez-Rubio, Elena, Giménez Mestre, María-José, Alvaro-Afonso, Francisco-Javier, Coronel, Pilar, and Sevillano, David
- Subjects
AMOXICILLIN ,CLAVULANIC acid ,TREATMENT of diabetic foot ,DIABETIC foot ,DRUG efficacy ,SKIN infections ,SOFT tissue infections ,STAPHYLOCOCCUS - Abstract
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
39. Long-Term Outcomes of Multidrug-Resistant Pseudomonas aeruginosa Bacteriuria: A Retrospective Cohort Study.
- Author
-
Moon, Chisook, Kang, Jin Suk, Mun, Seok Jun, Kim, Si-Ho, and Wi, Yu Mi
- Subjects
SOFT tissue infections ,JOINT infections ,URINARY tract infections ,INTENSIVE care units ,MULTIDRUG resistance - Abstract
The relationship between bacteriuria and subsequent symptomatic infections, particularly bacteraemia, has been a subject of ongoing research. We aim to investigate the clinical characteristics, long-term outcomes, and factors associated with subsequent symptomatic infection following an initial multidrug-resistant P. aeruginosa (MDRP) bacteriuria episode. A retrospective cohort study was conducted among patients with MDRP bacteriuria who were hospitalized at a tertiary care hospital from 2009 to 2018, with a 12-month follow-up period for each patient. The primary endpoint was the incidence of subsequent symptomatic MDRP infections at any site, and the secondary endpoint was the overall mortality rate. A total of 260 patients with MDRP bacteriuria were included in the analysis, of whom 155 patients (59.6%) had asymptomatic bacteriuria. Subsequent symptomatic MDRP infections were documented in 79 patients (30.3%) within 12 months of the initial bacteriuria episode: UTI (n = 47, 18.1%), pneumonia (n = 21, 8.1%), bacteraemia (n = 9, 3.5%), soft tissue infection (n = 7, 2.7%), and bone and joint infection (n = 4, 1.5%). Intensive care unit (ICU) acquisition and recurrent bacteriuria were independent risk factors of subsequent symptomatic infections in patients with MDRP bacteriuria. The overall mortality rate was 16.9%, with 31.8% of deaths estimated to be associated with MDRP infection. Solid tumours, cardiovascular diseases, chronic liver disease, chronic lung disease, ICU acquisition, absence of pyuria, and concurrent MDRP bacteraemia were independent predictors of mortality. MDRP bacteriuria has the potential for progression to symptomatic infection and associated mortality. Targeted interventions and prevention strategies were crucial to reduce subsequent infections in patients with MDRP bacteriuria, especially in high-risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Isolation of Staphylococcus pseudintermedius in Immunocompromised Patients from a Single Center in Spain: A Zoonotic Pathogen from Companion Animals.
- Author
-
Viñes, Joaquim, Verdejo, Miguel Ángel, Horvath, Laura, Vergara, Andrea, Vila, Jordi, Francino, Olga, Morata, Laura, Espasa, Mateu, Casals-Pascual, Climent, Soriano, Àlex, and Pitart, Cristina
- Subjects
SOFT tissue infections ,WHOLE genome sequencing ,SCIENTIFIC literature ,CATHETER-related infections ,PETS - Abstract
Staphylococcus pseudintermedius, a commensal opportunistic bacterium predominantly residing in the skin of companion animals, particularly dogs, has the potential to induce skin and soft tissue infections in pets, and zoonotic infections, including catheter-related complications. This study documents four cases of S. pseudintermedius infection or colonization in patients who had close contact with dogs or cats. Identification of the bacterial species was performed using MALDI-TOF mass spectrometry, and antibiotic susceptibility was determined using microdilution assay. DNA was sequenced using Nanopore technology followed by in silico analysis. Three isolates were multidrug resistant, including resistance to methicillin, with one belonging to the prevalent European lineage ST551, and the other two were attributed to a novel multilocus sequence type, ST2672. The remaining isolate was attributed to the novel multilocus sequence type ST2673 and was methicillin susceptible. All four isolates exhibited an array of virulence factors that contributed to colonization, damage to host immune cells, and biofilm formation. All the ST551 isolates included in the comparative analysis displayed clonality within the European continent. The importance of describing zoonotic infections associated with S. pseudintermedius resides in the scarcity of available scientific literature, further accentuated by its heightened resistance profile and potential complications, particularly in the context of catheter-related infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Pelvic Necrosis with Formation of a Pelvic "Cloaca" and Necrotizing Soft Tissue Infection After Radiation for Anal Squamous Cell Carcinoma.
- Author
-
Rivkin, Angeline C., Khan, Adil H., Mellgren, Anders F., Perez-Tamayo, Alejandra M., Chaudhry, Vivek, Bianchi, Elisa M., and Abdulhai, Mohamad A.
- Subjects
- *
INTENSITY modulated radiotherapy , *SOFT tissue infections , *URETERIC obstruction , *ANUS , *TECHNOLOGICAL innovations , *ANAL cancer - Abstract
Objective: Unusual clinical course Background: Anal squamous cell carcinoma (SCC) is a rare cancer commonly treated with the Nigro protocol, which combines chemotherapy and radiation. Patients who received radiation therapy prior to modern advances, such as computer-based tumor targeting, volumetric planning, and intensity-modulated radiation therapy, experience more acute and chronic adverse effects. Though exceedingly rare, radiation necrosis is of particular concern, as it can result in significant morbidity and mortality, including complex pelvic fistula formation and predisposition to potentially life-threatening necrotizing soft-tissue infections. Case Report: Here, we present a case of a 66-year-old woman with a prior history of anal SCC stage T3N×M0 who was treated with the Nigro protocol. Her treatment course was complicated by radiation proctitis, necessitating fecal diversion and ureteral strictures, requiring frequent stent exchanges. She presented 18 years after her cancer treatment, with widespread necrosis of her pelvic organs and surrounding soft tissue, resulting in formation of a large pelvic "cloaca", with a superimposed necrotizing soft-tissue infection. She was successfully treated by expedited resuscitation, septic source control, using multiple extensive debridements, and complete urinary diversion, utilizing a multidisciplinary team. Conclusions: This case highlights the importance of monitoring patients for signs of radiation toxicity, particularly in patients who received radiation prior to the latest technological advancements, as they are at increased risk of developing severe, late adverse effects decades after treatment. When these complications are recognized, early and aggressive intervention is required to spare the patient significant morbidity and mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience.
- Author
-
Leanza, Cristiana, Mascellino, Maria Teresa, Volpicelli, Lorenzo, Covino, Sara, Falletta, Antonio, Cancelli, Francesca, Franchi, Cristiana, Carnevalini, Martina, Mastroianni, Claudio M., and Oliva, Alessandra
- Subjects
PSEUDOMONAS aeruginosa infections ,SOFT tissue infections ,URINARY tract infections ,KLEBSIELLA pneumoniae ,TREATMENT effectiveness - Abstract
Introduction: Real-life experience with imipenem/cilastatin/relebactam (IMI/REL) for the treatment of KPC-producing Klebsiella pneumoniae complex (KPCKp) and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa (DTR-PA) infections is herein described. Methods: Adult patients with KPC-Kp or DTR-PA infections who received =48 h of IMI/REL were included. Clinical and microbiological outcomes were retrieved through the medical records. Primary outcome was clinical cure. Secondary outcomes included mortality from infection onset and adverse effects attributable to IMI/REL. Results: We included 10 patients with different infections caused by DTRPA (n = 4), KPC-Kp [n = 5, of which 3 ceftazidime/avibactam-resistant (CTV-R KPC-Kp), 2 CTV susceptible (CTV-S KPC-Kp)] or both DTR-PA/KPC-Kp (n = 1) successfully treated with IMI/REL: 3 hospital-acquired pneumonia, 1 ventilatorassociated pneumonia, 2 skin and soft tissue infections, 1 osteomyelitis, 2 bloodstream infections, 1 complicated urinary tract infection. Clinical cure was achieved in all cases. No patients died and no side effect were reported. Discussion: We reported the preliminary real-life experience on the successful and safe use of IMI/REL for the treatment of KPC-Kp or DTR-PA complicated infections, including pneumonia and bone infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Fulminant fatal pneumonia and bacteremia due to Aeromonas dhakensis in an immunocompetent man: a case report and literature review.
- Author
-
Lei Jiang, Qiquan Zhao, Dairong Li, Jia Gao, Xiaobing Zhang, Qian Shu, and Xiaoli Han
- Subjects
SOFT tissue infections ,RESPIRATORY organs ,LITERATURE reviews ,NUCLEOTIDE sequencing ,INTENSIVE care units - Abstract
Background: Aeromonas dhakensis is associated with soft tissue infection, bacteremia and gastroenteritis. Involvement of respiratory system in adults is extremely rare. We report a case of fulminant pneumonia and bacteremia due to A. dhakensis in a patient without underlying diseases. Case presentation: A 26-year-old man became ill suddenly with pneumonia after swimming in a river. Despite intensive support measures in the intensive care unit, he died 13 hours after admission and 4 days after his first symptoms. Autopsy showed abundant Gram-negative bacteria, massive inflammatory cell infiltration, edema, necrosis and hemorrhage in lung tissue. A. dhakensis was isolated from blood culture taken at admission and bronchoalveolar lavage fluid (BALF) after intubation. Moreover, A. dhakensis was also detected in lung tissue by metagenomic next-generation sequencing (mNGS) assay. The infection may have come from river water. Conclusion: In patients who develop a fulminant pneumonia after contacting an aquatic environment, A. dhakensis should be alerted and mNGS may aid in the detection of aquatic pathogens by being more sensitive and specific versus traditional bacterial culture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Mapping the evidence about the natural history of acute infections commonly seen in primary care and managed with antibiotics: a scoping review.
- Author
-
Boaitey, Kwame Peprah, Bakhit, Mina, and Hoffmann, Tammy C
- Subjects
- *
NATURAL history , *URINARY tract infections , *PRIMARY care , *SOFT tissue infections , *RESPIRATORY infections , *EVIDENCE gaps - Abstract
Background: Knowing the natural history of acute infections in primary care, defined as the course of a disease over time in the absence of specific therapy or treatment, can inform clinicians' and patients' expectations about illness recovery, but this evidence is fragmented across the literature. This scoping review aimed to map existing research and research gaps relevant to the natural history of acute infections. Methods: We searched MEDLINE, Embase and CENTRAL using a 2-phase hierarchical search approach. In Phase A, we focused on identifying systematic reviews synthesising natural history data for eligible infections (acute respiratory, urinary, and skin and soft tissue) and systematic reviews of treatment effectiveness (of RCTs with placebo or no treatment arm, or cohort studies). For infections without existing reviews, in Phase B, we searched for primary studies (placebo-controlled RCTs or cohort studies). Two reviewers independently screened and extracted the data (study characteristics, outcome data - e.g., symptom duration, proportion with resolution at various time points). Results: We identified 40 systematic reviews, reporting on 45 infections, most commonly (90%) respiratory tract infections. Six (15%) of these aimed to synthesise natural history information. Most reviews reported the proportion of participants with symptom resolution at various time point/s, with 58% providing data on mean symptom duration. Recovery data show the spontaneous resolution of some infections in some people. We found no eligible studies for cellulitis, ecthyma, carbuncle, and erysipelas. Conclusions: Our review has shown that natural history evidence exists for many common acute infections. It can be utilised by clinicians in implementing patient-centred antibiotic stewardship strategies in primary care. Future research should focus on generating natural history evidence for skin and soft tissue infections and urinary tract infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Cranial stair-step incision for minimizing postoperative complications in neuro-oncologic surgery: A propensity score-matched analysis.
- Author
-
Park, John B., Filo, Jean, Rahmani, Benjamin, Adebagbo, Oluwaseun D., Lee, Daniela, Escobar-Domingo, Maria J., Garvey, Shannon R., Arnautovic, Aska, Cauley, Ryan P., and Vega, Rafael A.
- Subjects
- *
CRANIOTOMY , *SURGICAL complications , *SOFT tissue infections , *PROPENSITY score matching , *INJURY complications ,TUMOR surgery - Abstract
Purpose: Craniotomies for tumor resection can at times result in wound complications which can be devastating in the treatment of neuro-oncological patients. A cranial stair-step technique was recently introduced as an approach to mitigate these complications, especially in this patient population who often exhibit additional risk factors including steroids, chemoradiation, and VEGF inhibitor treatments. This study evaluates our cranial stair-step approach by comparing its postoperative complications using propensity score matching with those of a standard craniotomy wound closure. Methods: A retrospective chart review was conducted on patients with intracranial neoplasms undergoing primary craniotomy at a single institution. Patients with prior craniotomies and less than three months of follow-up were excluded. Analyses were performed using R Studio. Results: 383 patients were included in the study, 139 of whom underwent the stair-step technique while the rest underwent traditional craniotomy closures. The stair-step cohort was older, had higher ASA classes, and had a higher prevalence of coronary artery disease. The stair-step patients were administered fewer steroids before (40.29% vs. 56.56%, p < 0.01) and after surgery (87.05% vs. 94.26%, p = 0.02), fewer immunotherapy (12.95% vs. 20.90%, p = 0.05), but they received more radiation preoperatively (15.11% vs. 8.61%, p = 0.05). They also underwent fewer operations for recurrences and residuals (0.72% vs. 10.66%, p = 0.01). On propensity score matching, we found 111 matched pairs with no differences except follow-up duration (p < 0.01). The stair-step group had fewer soft tissue infections (0% vs. 3.60%, p = 0.04), fewer total wound complications (0% vs. 4.50%, p = 0.02), was operated on less for these complications (0% vs. 3.60%, p = 0.04), and had a shorter length of stay (6 vs. 9 days, p < 0.01). Notably, the average time to wound complication in our cohort was 44 days, well within our exclusion criteria and follow-up duration. Conclusion: The cranial stair-step technique is safe and effective in reducing rates of wound complications and reoperation for neuro-oncologic patients requiring craniotomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Editorial: Insights in infectious agents and disease: 2022.
- Author
-
Cloeckaert, Axel
- Subjects
COVID-19 ,NEONATAL infections ,COMMUNICABLE diseases ,PATHOGENIC microorganisms ,MEDICAL personnel ,SMALL intestine diseases ,SOFT tissue infections - Abstract
This document is an editorial titled "Insights in infectious agents and disease: 2022" that provides an overview of recent developments in the field of bacterial, viral, and parasitic infectious diseases. It discusses major pandemics and epidemics caused by bacterial and viral diseases, including zoonotic pathogens transmitted from animals to humans. The editorial highlights various topics covered in research articles published in the journal, such as pathogenesis, antimicrobial resistance, epidemiology, diagnosis, and vaccine development. The document focuses on bats as reservoirs of zoonotic pathogens, diagnostic methods for identifying pathogens, vaccine development, and viral and parasitic infections. It emphasizes the importance of understanding microorganisms hosted by bats and the need for effective diagnostic strategies. The document also explores vaccine development for diseases like bubonic plague and COVID-19, as well as the pathogenesis of viral infections in reservoir hosts and specific infections caused by parasites. It concludes by highlighting ongoing research and advancements in the field of infectious diseases. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
47. Synthesis and preclinical evaluation of novel 18F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography.
- Author
-
Spoelstra, G. B., Blok, S. N., Reali Nazario, L., Noord, L., Fu, Y., Simeth, N. A., IJpma, F. F. A., van Oosten, M., van Dijl, J. M., Feringa, B. L., Szymanski, W., and Elsinga, P. H.
- Subjects
- *
POSITRON emission tomography , *BACTERIAL diseases , *SOFT tissue infections , *METHICILLIN-resistant staphylococcus aureus , *GRAM-positive bacteria - Abstract
Introduction: Bacterial infections are a major problem in medicine, and the rapid and accurate detection of such infections is essential for optimal patient outcome. Bacterial infections can be diagnosed by nuclear imaging, but most currently available modalities are unable to discriminate infection from sterile inflammation. Bacteria-targeted positron emission tomography (PET) tracers have the potential to overcome this hurdle. In the present study, we compared three 18F-labelled PET tracers based on the clinically applied antibiotic vancomycin for targeted imaging of Gram-positive bacteria. Methods: [18F]FB-NHS and [18F]BODIPY-FL-NHS were conjugated to vancomycin. The resulting conjugates, together with our previously developed [18F]PQ-VE1-vancomycin, were tested for stability, lipophilicity, selective binding to Gram-positive bacteria, antimicrobial activity and biodistribution. For the first time, the pharmacokinetic properties of all three tracers were compared in healthy animals to identify potential binding sites. Results: [18F]FB-vancomycin, [18F]BODIPY-FL-vancomycin, and [18F]PQ-VE1-vancomycin were successfully synthesized with radiochemical yields of 11.7%, 2.6%, and 0.8%, respectively. [18F]FB-vancomycin exhibited poor in vitro and in vivo stability and, accordingly, no bacterial binding. In contrast, [18F]BODIPY-FL-vancomycin and [18F]PQ-VE1-vancomycin showed strong and specific binding to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), which was outcompeted by unlabeled vancomycin only at concentrations exceeding clinically relevant vancomycin blood levels. Biodistribution showed renal clearance of [18F]PQ-VE1-vancomycin and [18F]BODIPY-FL-vancomycin with low non-specific accumulation in muscles, fat and bones. Conclusion: Here we present the synthesis and first evaluation of the vancomycin-based PET tracers [18F]BODIPY-FL-vancomycin and [18F]PQ-VE1-vancomycin for image-guided detection of Gram-positive bacteria. Our study paves the way towards real-time bacteria-targeted diagnosis of soft tissue and implant-associated infections that are oftentimes caused by Gram-positive bacteria, even after prophylactic treatment with vancomycin. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use–Associated Infective Endocarditis.
- Author
-
Figgatt, Mary C, Rosen, David L, Chu, Vivian H, Wu, Li-Tzy, and Schranz, Asher J
- Subjects
- *
BACTERIAL disease risk factors , *RISK assessment , *SOFT tissue infections , *DEATH , *RESEARCH funding , *HOSPITAL care , *BACTEREMIA , *INFECTIVE endocarditis , *DESCRIPTIVE statistics , *RETROSPECTIVE studies , *LONGITUDINAL method , *INTRA-articular injections , *KAPLAN-Meier estimator , *BACTERIAL diseases , *DISEASE relapse , *DATA analysis software , *NOSOLOGY - Abstract
Among a statewide cohort of 1874 patients surviving hospitalization for drug use–associated endocarditis during 2017–2020, the 3-year risk of death or future hospitalization was 38% (16% for death before later infection, 14% for recurrent endocarditis, 14% for soft tissue, 9% for bacteremia, 5% for bone/joint, and 4% for spinal infections). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Sequential Impact of Diabetes Mellitus on Deep Neck Infections: Comparison of the Clinical Characteristics of Patients with and without Diabetes Mellitus.
- Author
-
Liao, Ting-I, Ho, Chia-Ying, Chin, Shy-Chyi, Wang, Yu-Chien, Chan, Kai-Chieh, and Chen, Shih-Lung
- Subjects
ANTIBIOTICS ,DIABETES complications ,NECK ,SOFT tissue infections ,RISK assessment ,ACADEMIC medical centers ,COMPUTED tomography ,LOGISTIC regression analysis ,BLOOD cell count ,SEVERITY of illness index ,EVALUATION of medical care ,RETROSPECTIVE studies ,CHI-squared test ,MANN Whitney U Test ,MULTIVARIATE analysis ,DESCRIPTIVE statistics ,ODDS ratio ,KLEBSIELLA infections ,METRONIDAZOLE ,STATISTICS ,COMPARATIVE studies ,LENGTH of stay in hospitals ,CONFIDENCE intervals ,DATA analysis software ,STREPTOCOCCAL diseases ,C-reactive protein ,CEFTRIAXONE ,NONPARAMETRIC statistics ,PARVOVIRUS diseases ,DISEASE risk factors ,DISEASE complications ,SYMPTOMS - Abstract
Background: Deep neck infections (DNIs) can compromise the airway and are associated with high morbidity and mortality rates. Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia that is associated with several comorbidities. We compared the clinical characteristics of DNI patients with and without DM. Methods: This study recorded the relevant clinical variables of 383 patients with DNIs between November 2016 and September 2022; of those patients, 147 (38.38%) had DM. The clinical factors between DNI patients with and without DM were assessed. Results: Patients with DM were older (p < 0.001), had higher white blood cell counts (p = 0.029) and C-reactive protein levels (CRP, p < 0.001), had a greater number of deep neck spaces (p = 0.002) compared to patients without DM, and had longer hospital stays (p < 0.001). Klebsiella pneumoniae was cultured more frequently from patients with DM than those without DM (p = 0.002). A higher CRP level (OR = 1.0094, 95% CI: 1.0047–1.0142, p < 0.001) was a significant independent risk factor for DM patients with prolonged hospitalization. The lengths of hospital stays in patients with poorly controlled DM were longer than those with well-controlled DM (p = 0.027). Conclusions: DNI disease severity and outcomes were worse in patients with DM than those without DM. Antibiotics effective against Klebsiella pneumoniae should be used for DNI patients with DM. DNI patients with DM and high CRP levels had more prolonged hospitalizations. Appropriate blood glucose control is essential for DNI patients with DM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Medical imaging in melioidosis – 20‐year experience in a non‐endemic Australian city.
- Author
-
Earley, Joel and Warne, Richard
- Subjects
- *
MELIOIDOSIS , *SOFT tissue infections , *DIAGNOSTIC imaging , *INFECTIOUS arthritis , *BURKHOLDERIA pseudomallei , *ELECTRONIC health records - Abstract
Introduction Methods Results Conclusion Melioidosis may occasionally be encountered in non‐endemic areas and medical imaging is frequently used to identify and characterise sites of disease. The purpose of this study is to describe the spectrum of imaging findings encountered in melioidosis patients treated in the tertiary public hospitals of Perth, Western Australia, between 2002 and 2022.A database search and electronic medical record review was used to identify cases. Cases were included if they had Burkholderia pseudomallei isolated on culture and if they had at least one diagnostic imaging study performed at a Perth public tertiary hospital. The relevant imaging studies were reviewed, and imaging findings were recorded.Thirty‐six cases were identified. The most common disease manifestation was bacteraemia (72%, 26 cases), followed by pulmonary infection (58%, 21 cases), skin and soft tissue infection (22%, eight cases), prostate abscess (14%, five cases) and septic arthritis (6%, two cases). A previously unreported case of isolated melioid pleural effusion was identified, as was a case of reactivated chronic latent pulmonary melioidosis with an apparent delay of over 20 years between the onset of symptoms and the time of infection. In cases with pulmonary melioidosis, the major lung abnormalities on CT chest could be categorised into one of two distinct patterns: nodular‐predominant (78%) or consolidation‐predominant (22%).Further research is required to assess the utility of the pattern‐based categorisation of lung abnormalities on CT chest seen in the pulmonary melioidosis cases of this series. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.